News Briefs: Alignment Health Plan will cover Grail’s Galleri liquid biopsy | Dec. 9, 2021

  • Alignment Health Plan and Grail, LLC signed an agreement that will provide its members access to Galleri, a multicancer early detection blood test. Alignment is a national Medicare Advantage (MA) plan from Alignment Healthcare. The deal makes it the first MA plan to offer the liquid biopsy, which is used as a complement to recommended single cancer screenings and can detect more than 50 types of cancer. It is available by prescription only. New and existing plan members in select HMO and PPO plans in California and North Carolina will have access to Galleri starting Jan. 1. Read more
  • Angela Maas

    Angela has an extensive background of editing, reporting and writing for trade and consumer publications. She has written Radar on Specialty Pharmacy (formerly called Specialty Pharmacy News) since she joined AIS Health in 2005 and has broad knowledge of the various issues at play within the space. Before joining AIS Health, she was managing editor at Employee Benefit News and Employee Benefit News Canada and managing editor at HemAware (a hemophilia publication), Lupus Living and Momentum (a multiple sclerosis publication). She has a B.A. in English and an M.A. in British literature from Arizona State University.

Related Posts

The Latest
Meet Our Reporters

Meet Our Reporters

×
×